BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23880543)

  • 1. Fatal case of enterovirus 71 infection and rituximab therapy, france, 2012.
    Kassab S; Saghi T; Boyer A; Lafon ME; Gruson D; Lina B; Fleury H; Schuffenecker I
    Emerg Infect Dis; 2013 Aug; 19(8):1345-7. PubMed ID: 23880543
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lethal enterovirus myocarditis associated with rituximab and chemotherapy for follicular lymphoma].
    Alonso JJ; Cánovas A; Rubio G
    Med Clin (Barc); 2013 Nov; 141(10):459-60. PubMed ID: 23622890
    [No Abstract]   [Full Text] [Related]  

  • 3. Enterovirus 71 meningoencephalitis complicating rituximab therapy.
    Ahmed R; Buckland M; Davies L; Halmagyi GM; Rogers SL; Oberste S; Barnett MH
    J Neurol Sci; 2011 Jun; 305(1-2):149-51. PubMed ID: 21444094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance rituximab should be considered for patients with follicular lymphoma.
    Barr PM
    Clin Adv Hematol Oncol; 2014 Aug; 12(8):541-3. PubMed ID: 25356579
    [No Abstract]   [Full Text] [Related]  

  • 5. Severe anemia during rituximab maintenance therapy for follicular lymphoma.
    Liapis K; Harhalakis N; Stefanou G; Apostolidis J
    J Clin Oncol; 2012 Mar; 30(8):e95-6. PubMed ID: 22231048
    [No Abstract]   [Full Text] [Related]  

  • 6. Rituximab maintenance therapy for follicular lymphoma.
    Zhou H; Zhang B; Zhang J; Ni W; Hu Z
    Lancet; 2011 Apr; 377(9772):1150-1; author reply 1151-2. PubMed ID: 21459204
    [No Abstract]   [Full Text] [Related]  

  • 7. Fatal disseminated enterovirus infection in a patient with follicular lymphoma undergoing obinutuzumab maintenance therapy.
    Heger JM; Eichenauer DA; Kasper P; Böll B; Shimabukuro-Vornhagen A; Kochanek M
    Eur J Haematol; 2019 Sep; 103(3):268-271. PubMed ID: 31211882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opportunistic enteroviral meningoencephalitis: an unusual treatable complication of rituximab therapy.
    Ganjoo KN; Raman R; Sobel RA; Pinto HA
    Leuk Lymphoma; 2009 Apr; 50(4):673-5. PubMed ID: 19373672
    [No Abstract]   [Full Text] [Related]  

  • 9. Coxsackievirus A16 encephalitis during obinutuzumab therapy, Belgium, 2013.
    Eyckmans T; Wollants E; Janssens A; Schoemans H; Lagrou K; Wauters J; Maertens J
    Emerg Infect Dis; 2014 May; 20(5):913-5. PubMed ID: 24751368
    [No Abstract]   [Full Text] [Related]  

  • 10. A systematic review of comparative schedule-related toxicities with maintenance rituximab in follicular and mantle cell lymphomas.
    Nabhan C; Ollberding NJ; Villines D; Chiu BC; Caces DB; Valdez TV; Ghielmini M; Hsu Schmitz SF; Smith SM
    Leuk Lymphoma; 2014 Jun; 55(6):1288-94. PubMed ID: 23998254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatal Coxsackie meningoencephalitis in a patient with B-cell lymphopenia and hypogammaglobulinemia following rituximab therapy.
    Palacios T; Bartelt L; Scheld W; Lopes MB; Kelting SM; Holland S; Lipkin WI; Quan PL; Borish L; Lawrence M
    Ann Allergy Asthma Immunol; 2015 Aug; 115(2):148-50. PubMed ID: 26048250
    [No Abstract]   [Full Text] [Related]  

  • 12. Maintenance rituximab every 2 months is more toxic than every 3 months in patients with non-Hodgkin lymphoma.
    Rashidi A; Oak E; Bartlett NL
    Blood; 2015 May; 125(21):3354-5. PubMed ID: 25999445
    [No Abstract]   [Full Text] [Related]  

  • 13. [Laboratory diagnosis for enterovirus 71 infection].
    Shimizu H
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():389-92. PubMed ID: 16111282
    [No Abstract]   [Full Text] [Related]  

  • 14. [Rituximab-induced interstitial lung disease].
    Fernández Casares M; Espósito G; González A; Segovia J; Galperín Mde L; Del Valle E
    Medicina (B Aires); 2013; 73(4):343-5. PubMed ID: 23924535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enteroviral encephalitis in a patient with a marginal zone lymphomatreated with rituximab.
    Schilthuizen C; Berenschot HW; Levin MD
    Neth J Med; 2010 May; 68(5):221-3. PubMed ID: 20508271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of postremission therapy in follicular lymphoma: efficacy of rituximab maintenance.
    Roy R; Gordon LI
    J Natl Compr Canc Netw; 2011 May; 9(5):563-71. PubMed ID: 21550969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Balancing immunosuppression and infection: recurrent enterovirus encephalitis in SLE.
    Cheema S; Bunting E; Good C; Hajela V; Ridha BH; Saha RA
    Pract Neurol; 2019 Dec; 19(6):508-510. PubMed ID: 31171649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab maintenance for the treatment of patients with follicular lymphoma: an updated systematic review and meta-analysis of randomized trials.
    Vidal L; Gafter-Gvili A; Salles G; Dreyling MH; Ghielmini M; Hsu Schmitz SF; Pettengell R; Witzens-Harig M; Shpilberg O
    J Natl Cancer Inst; 2011 Dec; 103(23):1799-806. PubMed ID: 22021664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A severe pediatric infection with a novel enterovirus A71 strain, Thuringia, Germany.
    Karrasch M; Fischer E; Scholten M; Sauerbrei A; Henke A; Renz DM; Mentzel HJ; Böer K; Böttcher S; Diedrich S; Krumbholz A; Zell R
    J Clin Virol; 2016 Nov; 84():90-95. PubMed ID: 27771495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic Characterization of Cytokine Responses to Enterovirus 71 and Coxsackievirus A16 Infection in Children.
    Zhang SY; Xu MY; Xu HM; Li XJ; Ding SJ; Wang XJ; Li TY; Lu QB
    Medicine (Baltimore); 2015 Jul; 94(27):e1137. PubMed ID: 26166120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.